Depo-Provera injection and Estrogens (Conjugated/Equine) and Bazedoxifene
Determining the interaction of Depo-Provera injection and Estrogens (Conjugated/Equine) and Bazedoxifene and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Talk to your doctor before using bazedoxifene/conjugated estrogens together with medroxyPROGESTERone. Generally, patients treated with bazedoxifene/conjugated estrogens should not receive medroxyPROGESTERone or other progestin-containing medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: The use of bazedoxifene-conjugated estrogens in combination with progestins has not been evaluated. Safety and efficacy of this combination are unknown.
MANAGEMENT: Women treated with bazedoxifene-conjugated estrogens should not receive progestins, which have often been used to mitigate the risk of endometrial cancer associated with estrogen therapy in patients with an intact uterus. Since the bazedoxifene component is intended to reduce the risk of endometrial hyperplasia, a possible precursor to endometrial cancer, there should be no need for progestin therapy under such circumstances.
- "Product Information. Duavee (bazedoxifene-conjugated estrogens)." Pfizer U.S. Pharmaceuticals Group, New York, NY.
Generic Name: medroxyprogesterone
Brand name: Depo-Provera, Depo-subQ provera 104, Provera, Depo-Provera Contraceptive
Synonyms: Depo-Provera
Generic Name: bazedoxifene / conjugated estrogens
Brand name: Duavee
Synonyms: Bazedoxifene and conjugated estrogens
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Depo-Provera injection-Estrogens (Conjugated/Equine) and Medroxyprogesterone
- Depo-Provera injection-Estrogens (Conjugated/Equine, Systemic)
- Depo-Provera injection-Estrogens (Conjugated/Equine, Topical)
- Depo-Provera injection-Estrogens (Esterified)
- Depo-Provera injection-Estrogens (Esterified) and Methyltestosterone
- Depo-Provera injection-Estropipate
- Estrogens (Conjugated/Equine) and Bazedoxifene-Depo-subQ provera 104
- Estrogens (Conjugated/Equine) and Bazedoxifene-Depo-SubQ Provera 104 injection
- Estrogens (Conjugated/Equine) and Bazedoxifene-Depo-Testosterone
- Estrogens (Conjugated/Equine) and Bazedoxifene-DepoCyt
- Estrogens (Conjugated/Equine) and Bazedoxifene-DepoDur
- Estrogens (Conjugated/Equine) and Bazedoxifene-Deprizine